Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements
about
A small molecule inhibitor of ETV1, YK-4-279, prevents prostate cancer growth and metastasis in a mouse xenograft modelEpigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors.Association of DSC3 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosisAn Integrative Genomics Approach for Associating Genome-Wide Association Studies Information With Localized and Metastatic Prostate Cancer PhenotypesTranscriptome instability as a molecular pan-cancer characteristic of carcinomasERG induces epigenetic activation of Tudor domain-containing protein 1 (TDRD1) in ERG rearrangement-positive prostate cancer.Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors.Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contextsConference report from the 2015 OECI Oncology Days, Portugal, 22-24 June-tumour heterogeneity and next generation sequencing: morphology and technologyA Novel Quantitative Multiplex Tissue Immunoblotting for Biomarkers Predicts a Prostate Cancer Aggressive Phenotype.ETS transcription factors in embryonic vascular development.Cancer subclonal genetic architecture as a key to personalized medicine.Androgen receptor and gene network: Micromechanics reassemble the signaling machinery of TMPRSS2-ERG positive prostate cancer cells.Maintaining and reprogramming genomic androgen receptor activity in prostate cancer.Identification of TDRD1 as a direct target gene of ERG in primary prostate cancer.Oncogenic mechanisms of HOXB13 missense mutations in prostate carcinogenesis.TMEM45B, up-regulated in human lung cancer, enhances tumorigenicity of lung cancer cells.The Germ Cell Gene TDRD1 as an ERG Target Gene and a Novel Prostate Cancer Biomarker.TMEM45B promotes proliferation, invasion and migration and inhibits apoptosis in pancreatic cancer cells.Calcium Channel Blocker Use and Risk of Prostate Cancer by TMPRSS2:ERG Gene Fusion Status.Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential.Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer.Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinoma.Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer.NCOA2 is a candidate target gene of 8q gain associated with clinically aggressive prostate cancer.Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer.Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integrationUncovering potential downstream targets of oncogenic GRPR overexpression in prostate carcinomas harboring ETS rearrangements.Integrative genomic analysis for the discovery of biomarkers in prostate cancer.Novel 5' fusion partners of ETV1 and ETV4 in prostate cancer.A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting TMEM97.
P2860
Q27322372-9B8234A5-12C5-4012-82A0-867D0FF0F2CFQ27323950-AAFB697D-B94E-402B-BE91-569814EFD11CQ28541425-351AB960-4FFD-40F5-91A7-A81F1E66B484Q33565740-BC90BBC7-DB21-49FF-A916-3D3B5365C074Q34041693-573B81CA-6164-4901-A5FD-66660703E6EAQ34652823-FB3E010D-BBD5-4827-A67B-6305099D61B2Q35689954-F8E556A1-D2CE-41A1-8E68-E0B03747E7A5Q35741647-657D8183-8484-4248-956F-E3087968527EQ35981197-313ED78A-494F-44F4-A6BE-2FFC99CEBAABQ36584742-68E60ACF-460A-4421-968B-A56C3790F315Q37077576-4BDF62FE-194B-4D1F-89F9-B45F46CDEE0FQ37448116-0A2747E3-6355-4BC3-A985-64AA5AE11D97Q37727814-A8447C5B-63F3-4C26-88F0-8513C5D07169Q38190362-F48FFAA9-6980-4D41-9D39-EF0029FBB50AQ38318517-B563BE00-2D45-4FB8-96D8-7FE6CB679610Q38723089-7E35EBC5-DB80-4177-8673-9A53BA14BA03Q38737078-31C45078-3AF7-42BA-8C96-F6D92E0A7EA5Q38766041-77FA9CBB-8E7B-490B-98C2-E6F237158D9CQ38775892-69609378-D160-43CF-9A6D-E55DF4463E8CQ38810096-E57E8063-B73D-4D82-9BB9-6AAFCB6F2618Q38957460-4178F5DD-6A16-4B9E-8E1B-51AE3CDF2D2BQ38983831-3D3231E6-5C93-48A3-B2A6-D7FF29647093Q39237435-638C9FCC-1FE5-4FEA-A488-8674B9D9D919Q39909790-1D9EBC7E-7FF2-4C10-ACDA-392092363942Q40073572-D2A77D11-F718-4270-B2B6-423949E9F80FQ41261272-CE9C6770-0B55-48EC-80B6-FED94F8BF183Q41879186-3430D9D1-EA23-479F-A98D-A5D3A10D557AQ42430884-C5F9ABC5-FBA5-4F3B-97E7-B4B9A03623E6Q42723558-F155F71A-D985-4762-8FF3-B85A98CC2544Q43119456-E22A8D7D-30B0-4845-A263-8A55DFB42FB7Q52431156-001FB206-DAB3-4635-8708-6F98F1ACC166
P2860
Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Molecular subtyping of primary ...... f different ETS rearrangements
@en
Molecular subtyping of primary ...... different ETS rearrangements.
@nl
type
label
Molecular subtyping of primary ...... f different ETS rearrangements
@en
Molecular subtyping of primary ...... different ETS rearrangements.
@nl
prefLabel
Molecular subtyping of primary ...... f different ETS rearrangements
@en
Molecular subtyping of primary ...... different ETS rearrangements.
@nl
P2093
P2860
P50
P356
P1433
P1476
Molecular subtyping of primary ...... f different ETS rearrangements
@en
P2093
Anita Sveen
Franclim R Ribeiro
Ian G Mills
Ragnhild A Lothe
Rolf I Skotheim
P2860
P304
P356
10.1593/NEO.12600
P407
P50
P577
2012-07-01T00:00:00Z